100% Secure Checkout Secure
Third-Party HPLC Tested HPLC Tested
Accurately measure your Body Protection Compound (BPC-157) healing protocols. Enter your vial size, bacteriostatic water volume, and desired dose to calculate the exact syringe draw.
Standard BPC-157 vials are typically 5mg or 10mg.
Volume of water used to reconstitute the lyophilized powder.
BPC-157 is typically dosed in micrograms (e.g., 250mcg, 500mcg).
Select the maximum capacity of your U-100 insulin syringe.
Draw exactly to the 10 unit mark (red line) on a 1mL (100 Unit) insulin syringe.
Concentration
2.50 mg/mL
Dose per Unit (1/100 mL)
25.0 mcg/Unit
Volume to Inject
0.10 mL
Select a BPC-157 research protocol below to view its specific dosing schedule.
| Phase | Timeline | Dosage & Frequency |
|---|---|---|
| Initiation | Days 1 - 3 | 250 mcg (1x Daily) |
| Active Healing | Weeks 1 - 4 | 250 - 500 mcg (2x Daily) |
| Taper | Week 5 | 250 mcg (1x Daily) |
| Resolution | Week 6+ | Discontinue or move to Maintenance |
For localized injuries (e.g., tendon tear), subcutaneous injection near the site of injury is often preferred, though systemic subcutaneous injection is also highly effective.
Body Protection Compound
A synthetic peptide sequence known for its remarkable systemic healing properties, particularly for tendons, ligaments, and the gastric system.
BPC-157 works primarily by promoting angiogenesis—the physiological process through which new blood vessels form from pre-existing vessels. It heavily modulates VEGF (Vascular Endothelial Growth Factor).
By massively increasing blood flow to localized injury sites (such as avascular tendons and ligaments that normally heal very slowly), it supplies the necessary nutrients and fibroblasts required for rapid tissue remodeling.
Result: Accelerated healing of tendon-to-bone injuries, ligament damage, and a powerful cytoprotective effect on the gastrointestinal tract (healing ulcers and leaky gut).
BPC-157 is notably more stable than many other peptides. However, standard lyophilized peptide care applies. Store unmixed vials in the freezer (-20°C). Once reconstituted with Bacteriostatic Water, the peptide must be refrigerated (2°C - 8°C).
Unlike long-acting metabolic peptides, BPC-157 has a very short biological half-life estimated at 4 to 6 hours.
Because it clears from the system rapidly, maintaining a steady-state blood plasma concentration requires daily—or preferably twice daily—subcutaneous administration to maximize the continuous healing window.
Because BPC-157's primary mechanism involves rapid angiogenesis (growing new blood vessels), it should be strictly avoided in subjects with active cancers or highly proliferative tumor diseases.
Caution: While BPC-157 does not cause cancer, promoting angiogenesis theoretically provides increased blood supply to pre-existing malignant cells.